One of the best things about Seeking Alpha is the availability of research regarding stocks so risky that virtually no Wall Street advisors or analysts who care about keeping their jobs would ever consider recommending them – however large these stocks’ upside might be. The subject of this report is a company sufficiently dicey to earn its latest audit report a going concern qualification, but whose most recent quarterly results and guidance strongly suggest that a remarkable turnaround is underway.
Zynex (OTCQB:ZYXI) designs, manufactures, rents, and sells non-invasive medical devices, with a focus on electrotherapy products. Applications of electrotherapy include pain management, as well as stroke and injury rehabilitation. The use of electrotherapy for pain management has been cited as a useful means of fighting iatrogenic opioid dependence.
According to a 10Q filed by Zynex on 11/14/16:
“During the fourth quarter of 2015, the electrotherapy industr y experienced a significant development when the Company’s largest competitor (DJO/Empi) announced the closure of their Empi electrotherapy division. Empi previously held a large share of the electrotherapy market. Management believes this presents a significant growth opportunity for the Company. The Company has recruited many former Empi sales representatives, including those in areas where it had no previous representation. In addition, during 2016, the Company’s orders have been steadily increasing as compared to 2015. To focus on growth and the potential for future positive cash flow, the Company has committed its limited resources to the new salesforce, including the supporting product production and supporting administrative (customer service and billing) personnelThrough September 30, 2016, we have recruited and retained over 70 former Empi sales representatives.”
Best Medical Stocks To Invest In 2017: American Electric Power Company, Inc.(AEP)
- [By Richard Stavros]
Southern Company’s total return is down 6.4 percent over the last year versus the S&P 500′s gain of 17.7 percent. But even against its sector peers, the utility has been a laggard: Over that same period, Duke Energy Corp (NYSE: DUK) is up 5.8 percent, and American Electric Power Co (NYSE: AEP) has returned 2.1 percent.
Best Medical Stocks To Invest In 2017: First Majestic Silver Corp.(AG)
- [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha) Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
Gainers Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory. SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award. The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory. Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday. Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology. AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday. Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday. First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce. Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to
Best Medical Stocks To Invest In 2017: Marvell Technology Group Ltd.(MRVL)
- [By Lisa Levin]
Marvell Technology Group Ltd. (NASDAQ: MRVL) shares shot up 10 percent to $14.70 after the company reported upbeat Q3 results and announced a $1 billion share buyback.
- [By Monica Gerson] Related GNCA 20 Biggest Mid-Day Gainers For Friday 15 Stocks Which Plummeted Three Days On Increasing Volume Related BHI A Peek Into The Markets: U.S. Stock Futures Rise Following Strong Chinese Manufacturing Report Benzinga's M&A Chatter for Monday October 31, 2016 Baker Hughes – I Like The Deal With GE On The Back Of De-Risking And Synergies (Seeking Alpha)
Gainers Genocea Biosciences Inc (NASDAQ: GNCA) shares rose 13.3 percent to $4.08 in pre-market trading after the company presented a new 12 month data on genital herpes immunotherapy GEN-003. Baker Hughes Incorporated (NYSE: BHI) shares rose 8.2 percent to $59.00 in pre-market trading. General Electric Co. (NYSE: GE) is said to be in talks to acquire Baker Hughes, according to sources as reported by Dow Jones on Thursday. A deal could be valued at as much as $30 billion, the sources said. However, Bloomberg later reported that a GE spokesperson said they are is in talks with Baker Hughes regarding possible partnerships, but not an acquisition. Sanofi SA (ADR) (NYSE: SNY) rose 8 percent to $40.20 in the pre-market trading after the company posted upbeat quarterly earnings and lifted its full-year profit forecast. Cirrus Logic, Inc. (NASDAQ: CRUS) rose 6.6 percent to $55.20 in pre-market trading after the company reported better-than-expected results for its third quarter. Alliance Resource Partners, L.P. (NASDAQ: ARLP) shares rose 5.3 percent to $24.75 in pre-market trading following results for the quarter ended September 30, 2016. Its net income in the quarter gained 7.7 percent to $89.8 million. Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 5 percent to $13.78 in pre-market trading after dropping 2.09 percent on Thursday. Community Health Systems (NYSE: CYH) rose 4.4 percent to $5.27 in
- [By Shauna O’Brien]
On Tuesday, JP Morgan announced that it has raised its rating on Marvell Technology Group Ltd. (MRVL) .
The firm has upgraded MRVL from “Neutral” to “Overweight,” and has given the company a $16 price target. This price target suggests a 19% upside from the stock’s current price of $12.91.
Marvell Technology shares were up 37, or 2.94%, during Tuesday morning trading. The stock is up 78% YTD.
- [By Peter Graham]
The Q2 2017 earnings report for mid cap fabless semiconductor stock Marvell Technology Group Ltd (NASDAQ: MRVL) is scheduled for before the market opens on Tuesday (September 6th). We had Marvell Technology Groupin our SmallCap Network Elite Opportunity (SCN EO) portfolio back in 2013 becauseits fundamental and technical context appeared very attractive at the time and the company’s products also drive Samsung’s family of mobile devices. Our SCN EO newsletter noted in May 2013:
- [By Lisa Levin]
On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).